MAGI3–AKT3 fusion in breast cancer amended

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature

• Publication date

  2015-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature14265PMID 25877207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

  2014cited by this paper
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

  2013cited by this paper
• STAR: ultrafast universal RNA-seq aligner

  2013cited by this paper
• Novel MIR143‐NOTCH fusions in benign and malignant glomus tumors

  2013cited by this paper
• Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities

  2012cited by this paper
• Sequence analysis of mutations and translocations across breast cancer subtypes

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Triple negative breast cancer: unmet medical needs

  2011cited by this paper
• Functionally Recurrent Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer

  2011cited by this paper
• Integrative Genomics Viewer

  2011cited by this paper
• Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.

  2011cited by this paper
• FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data

  2010cited by this paper
• The genomic complexity of primary human prostate cancer

  2010cited by this paper
• TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.

  2006cited by this paper
• Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

  2005cited by this paper

• The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances

  2024cites this paper
• Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer.

  2023cites this paper
• Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy

  2022cites this paper
• GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells

  2022cites this paper
• Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.

  2021cites this paper
• AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition

  2021cites this paper
• Mechanics of molecular beacons for mRNA detecting

  2021cites this paper
• The Role of Cell-Free Circulating DNA in the Diagnosis and Prognosis of Breast Cancer

  2021cites this paper
• A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer

  2021cites this paper
• Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer

  2021cites this paper
• Landscape analysis of adjacent gene rearrangements reveals BCL2L14–ETV6 gene fusions in more aggressive triple-negative breast cancer

  2020cites this paper
• Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.

  2020cites this paper
• Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven Cancer.

  2019cites this paper
• Distinct functions of AKT isoforms in breast cancer: a comprehensive review

  2019cites this paper
• MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

  2018cites this paper
• Recurrent and functional regulatory mutations in breast cancer

  2017cites this paper
• Bioinformatic approaches for identifying single nucleotide variants and profiling alternative expression in cancer transcriptomes

  2017cites this paper
• High-confidence fusion gene detection in different tumor entities & biomarker discovery in breast cancer

  2017cites this paper
• Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers

  2016cites this paper
• Involvement of Tight Junction Plaque Proteins in Cancer

  2016cites this paper
• Nanoscale bio-platforms for living cell interrogation: current status and future perspectives.

  2016cites this paper
• Cancer: hunting rare somatic mutations

  2016cites this paper
• Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants

  2016cites this paper
• Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications

  2016cites this paper
• Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers Supplementary Issue: Biomarkers and their Essential Role in the Development of Personalised Therapies

  2016cites this paper